AOD 96045

What Is AOD 9604?

AOD 9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone. It is studied in laboratory, analytical, and preclinical research settings for its relationship with lipid metabolism, adipose tissue signaling, lipolytic pathway activity, and metabolic communication.

AOD 9604 is commonly described as a modified hGH fragment corresponding to the 177–191 region with an additional tyrosine residue at the N-terminus. Unlike full-length growth hormone, AOD 9604 is studied for more targeted research involving metabolic signaling and adipose-related pathways rather than broad growth hormone activity.

Research involving AOD 9604 has explored its relationship with adipocyte response, lipid mobilization, fat oxidation processes, beta-adrenergic pathway interaction, cellular energy utilization, and body-composition-related mechanisms in experimental models.

Because of its selective peptide structure and metabolic research profile, AOD 9604 remains a compound of interest in studies focused on lipid metabolism, adipose tissue regulation, endocrine-metabolic communication, and energy-balance research models.

AOD 9604 Profile

Primary Research Focus: Lipid metabolism, lipolytic signaling, adipose tissue regulation, fat oxidation, and energy-balance research models.

Certificate of Analysis

Third-party testing documentation available for purity and analytical verification.

AOD 9604 Research Overview

AOD 9604 is commonly discussed in research involving lipid metabolism, adipose tissue signaling, lipolytic pathway activity, cellular energy utilization, and body-composition-associated mechanisms.

Laboratory and preclinical research involving AOD 9604 has examined:

• Lipolytic pathway activity
• Adipose tissue metabolism
• Energy regulation mechanisms
• Metabolic signaling pathways
• Fat oxidation processes
• Cellular metabolic communication
• Adipocyte response models
• Endocrine-metabolic pathway interaction
• Beta-adrenergic pathway interaction

In controlled research environments, AOD 9604 is studied as a peptide tool for understanding how modified hGH fragments may interact with adipose tissue signaling, lipid metabolism pathways, and metabolic regulation models.

History and Development

AOD 9604 was developed through research focused on isolating specific regions of human growth hormone associated with metabolic signaling while minimizing broader systemic growth hormone activity.

Early investigations examined whether the C-terminal region of hGH could influence adipose metabolism independently of full growth hormone functionality.

Over time, AOD 9604 became increasingly studied in laboratory, preclinical, analytical, and metabolism-related research models involving lipid mobilization, adipose tissue signaling, energy-balance pathways, and cellular metabolic regulation.

AOD 9604 Structure

Primary Research Focus: Lipid metabolism, lipolytic signaling, adipose tissue regulation, energy balance, fat oxidation, and metabolic pathway research.

Research Findings

AOD 9604 has been studied across metabolic and physiological research models involving adipose tissue signaling, lipid metabolism pathways, fat oxidation activity, and energy regulation mechanisms.

Published investigations have examined its association with lipolytic signaling, adipocyte metabolism, beta-adrenergic pathway interaction, lipid oxidation, and body-composition-related mechanisms in experimental settings.

Key Areas of Investigation

• Metabolic Research: Lipolytic pathway signaling, fat oxidation mechanisms, lipid mobilization, cellular fuel utilization, and energy-balance regulation.
• Adipose Tissue Research: Adipocyte communication, adipose tissue signaling, lipid metabolism, and fat-storage pathway models.
• Cellular Research: Cellular metabolic activity, energy utilization, metabolic communication, and pathway regulation in experimental models.
• Physiological Research: Body-composition-related mechanisms, endocrine-metabolic interaction, obesity-related models, and adipose tissue response pathways.
• Mechanistic Research: Beta-adrenergic pathway interaction, lipolytic sensitivity, lipid oxidation, and metabolic signaling activity.

Mechanism-Based Research Interest

AOD 9604 is studied because it connects several important metabolic and adipose tissue-related research pathways, including:

• Lipolytic pathway activity
• Adipose tissue signaling
• Fat oxidation processes
• Lipid mobilization pathways
• Cellular energy utilization
• Metabolic signaling activity
• Beta-adrenergic pathway interaction
• Body-composition-related mechanisms
• Endocrine-metabolic communication

This makes AOD 9604 a useful investigational peptide for studying metabolic regulation, adipose tissue signaling, lipid metabolism pathways, and energy-balance mechanisms in controlled laboratory settings.

Research Applications

AOD 9604 may be useful in controlled research models focused on:

• Lipid metabolism research
• Adipose tissue signaling models
• Lipolytic pathway studies
• Fat oxidation mechanism research
• Metabolic communication models
• Energy-balance pathway studies
• Adipocyte response research
• Beta-adrenergic pathway interaction
• Body-composition-related experimental models
• Endocrine-metabolic signaling research

What Researchers May Document

In controlled research environments, researchers may document broad patterns related to:

• Adipocyte response models
• Lipid mobilization markers
• Metabolic pathway activity
• Fat oxidation research notes
• Energy-utilization observations
• Beta-adrenergic pathway interaction
• Cellular metabolic communication
• Protocol consistency
• Compound handling and reconstitution observations

The purpose of AOD 9604 research is not to promise outcomes. The purpose is to provide a structured compound for studying adipose tissue signaling, metabolic communication, and lipid metabolism mechanisms.

The Purple Standard™

Every vial supplied by Purple Peptides is handled according to the Purple Standard™. This includes third-party testing, purity verification, controlled storage practices, batch tracking, and internal rejection of any lot that does not meet required quality thresholds.

The Purple Standard™ exists to support consistency, documentation, and research confidence across every Purple Peptides product.

Investigational Research Context

AOD 9604 should be considered an investigational research compound. Available research includes laboratory, preclinical, analytical, and limited clinical-context studies. Findings should not be interpreted as approved therapeutic, clinical, veterinary, cosmetic, metabolic, body-composition, or human-use outcomes.

This product is supplied for laboratory research only and is not intended for human consumption, clinical use, veterinary use, supplementation, diagnostic use, or self-experimentation.

Scientific References

Need Help?

If you have questions regarding certificates of analysis, product documentation, or general research inquiries, our support team is here to assist.